You are here

US insurers step up discount war against Big Pharma

Move has expanded to niche fields where drugmakers used to charge their highest prices

Large drugmakers are focusing their research on diseases that do not have adequate treatments and finding ways to differentiate their products from competitors in terms of effectiveness and convenience.

San Francisco

THE world's biggest drugmakers face a new reality when it comes to US pricing for their products as insurers use aggressive tactics to extract steep price discounts, even for the newest medications.

Big Pharma executives acknowledged the depth of change last week...

Market voices on: